Calendar · pharmadog

Sign In Subscribe

COMPLETEDphase readoutNCT03354234: Evaluation of the ORTHO-LBNP System

Sponsor: Military Institute of Aviation Medicine. Phase: NA. Conditions: Orthostatic Hypotension, Ischemia, Hypoxia

full page →ctgov ↗

COMPLETEDphase readoutNCT01619709: Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Intracerebral Hemorrhage

full page →ctgov ↗

TERMINATEDphase readoutNCT04057664: A Group Therapy Based on the Bio-psycho-social Treatment Approach for Women With Chronic Pelvic and Chronic Belly Pain

Sponsor: Swiss Paraplegic Research, Nottwil. Phase: . Conditions: Pain, Chronic, Pain, Pelvic, Pain, Abdominal, Depression, Sex Disorder, Endometriosis

full page →ctgov ↗

RECRUITINGphase readoutNCT06282809: The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

Sponsor: HistoSonics, Inc.. Phase: NA. Conditions: Pancreas Cancer, Adenocarcinoma of the Pancreas, Pancreatic Cancer, Tumor of Pancreas

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07342309: Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States

Sponsor: Boehringer Ingelheim. Phase: . Conditions: Metastatic Breast Cancer

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07490899: Combined Nutrition and Parenting Study

Sponsor: University of South Carolina. Phase: PHASE3. Conditions: Early Childhood Development (ECD)

full page →ctgov ↗

COMPLETEDphase readoutNCT07119099: The relatıonshıp Between Upper Extremity Exercise Test and Exercise Capacity ın patıents wıth Idiopathic Pulmonary Fibrosis

Sponsor: Marmara University. Phase: . Conditions: Idiopathic Pulmonary Fibrosis (IPF)

full page →ctgov ↗

RECRUITINGphase readoutNCT07260799: Clinical Performance of Capillary Blood Samples Collected Using the Tasso+ Serum Gel Capillary Blood Collection System for Clinical Chemistry Testing of 14 Analytes on an Abbott Alinity Analyzer

Sponsor: Tasso Inc.. Phase: . Conditions: Serum Analytes

full page →ctgov ↗

RECRUITINGphase readoutNCT07244432: Post-ERCP Pancreatitis - Prophylactic Measures Implementation Study (PEP-PROMIS)

Sponsor: Branislav Kuncak. Phase: . Conditions: Pancreatitis, Acute, ERCP, Prophylaxis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06299098: A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Obesity

full page →ctgov ↗

RECRUITINGphase readoutNCT05030298: Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Malignant Glioma

full page →ctgov ↗

COMPLETEDphase readoutNCT04087798: Controlling Hypertension Through Education and Coaching in Kidney Disease

Sponsor: University of Michigan. Phase: NA. Conditions: Chronic Kidney Diseases, Chronic Disease, Chronic Kidney Disease, Stage 3 (Moderate), Chronic Kidney Disease, Stage 4 (Severe), Chronic Kidney Disease Stage 5, Hypertension

full page →ctgov ↗

RECRUITINGphase readoutNCT07361263: Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: AVP Deficiency, Diabetes Insipidus

full page →ctgov ↗

COMPLETEDphase readoutNCT07052487: Effectiveness of Post Isometric Relaxation Technique Versus Simple Stretching Exercises for Pain and Physical Activity in Young Females With Primary Dysmenorrhea in Peshawar

Sponsor: Khyber Medical University Peshawar. Phase: NA. Conditions: Dysmenorrhea, Menstrual Pain

full page →ctgov ↗

RECRUITINGphase readoutNCT05755087: Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma

Sponsor: Lapo Alinari. Phase: PHASE1. Conditions: Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05660187: VIRtual Versus UsuAL In-office Care for Multiple Sclerosis (VIRTUAL-MS)

Sponsor: The Cleveland Clinic. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07214987: PDT For Induction Therapy For Head And Neck Cancer

Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Squamous Cell Carcinoma, Head and Neck Cancer Squamous Cell Carcinoma, Head and Neck Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT04640987: Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback

Sponsor: Porteus, Matthew, MD. Phase: PHASE1. Conditions: Hematologic Diseases

full page →ctgov ↗

RECRUITINGphase readoutNCT07547787: A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)

Sponsor: Akeso. Phase: . Conditions: Locally Advanced Unresectable or Metastatic Gastric Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07470593: Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.

Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Type 1 Diabetes (T1D)

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07094893: Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status

Sponsor: Gruppo Oncologico del Nord-Ovest. Phase: PHASE4. Conditions: Colorectal Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT06044493: MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

Sponsor: Chong Kun Dang Pharmaceutical. Phase: PHASE4. Conditions: Kidney Transplant

full page →ctgov ↗

COMPLETEDphase readoutNCT05411393: Synergizing Home Health Rehabilitation Therapy

Sponsor: University of Florida. Phase: NA. Conditions: Frailty, Frail Elderly, Occupational Therapy, Activities of Daily Living, Home Health Care, Functional Status, Physical Functional Performance, Rehabilitation, Treatment Outcome, Health Services for the Aged

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04467021: Cancer and Blood Pressure Management, CARISMA Study

Sponsor: ECOG-ACRIN Cancer Research Group. Phase: NA. Conditions: Cardiovascular Disorder, Chronic Kidney Disease, Metastatic Renal Cell Carcinoma, Metastatic Thyroid Gland Medullary Carcinoma, Stage IV Renal Cell Cancer AJCC v8, Stage IV Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8

full page →ctgov ↗

COMPLETEDphase readoutNCT07005414: Efficacy of Bumetanide in Children With Autism Spectrum Disorder Guided by Peripheral Blood Biomarkers and Machine Learning Models

Sponsor: Fei Li. Phase: PHASE2. Conditions: Autism Spectrum Disorder

full page →ctgov ↗

COMPLETEDphase readoutNCT06391814: Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01)

Sponsor: Ciusss de L'Est de l'Île de Montréal. Phase: NA. Conditions: EBV Associated Lymphoma

full page →ctgov ↗

RECRUITINGphase readoutNCT06957314: A Study of Hospital-at-Home for People Receiving Tarlatamab

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Small-cell Lung Cancer, Small Cell Lung Carcinoma

full page →ctgov ↗

RECRUITINGphase readoutNCT00131014: Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

Sponsor: Dana-Farber Cancer Institute. Phase: . Conditions: Non-Hodgkin's Lymphoma, Hodgkin's Disease, Leukemia, Lymphocytic, Chronic, Lymphoproliferative Disorders

full page →ctgov ↗

COMPLETEDphase readoutNCT03256916: Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix

Sponsor: Tata Memorial Hospital. Phase: PHASE3. Conditions: Carcinoma Cervix,Stage III

full page →ctgov ↗

RECRUITINGphase readoutNCT03093116: A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Sponsor: Turning Point Therapeutics, Inc.. Phase: PHASE1. Conditions: Locally Advanced Solid Tumors, Metastatic Solid Tumors

full page →ctgov ↗

RECRUITINGphase readoutNCT07345806: A Pilot Study on an ACT-Based Program for Individuals With Special Needs and Their Caregivers

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Parenting Stress, Psychological Flexibility

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT00581906: Dynamic Contrast Enhanced MRI (DCE-MRI) Diffusion Weighted MRI (DW-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Head and Neck Cancer

full page →ctgov ↗

WITHDRAWNphase readoutNCT07071584: Evaluation of a Multi-electrode Prosthesis Control System for Real-world Tasks Performance in Individuals With Upper Limb Transradial Amputation

Sponsor: Phantom Neuro Inc.. Phase: NA. Conditions: Upper Limb Amputation Below Elbow

full page →ctgov ↗

COMPLETEDphase readoutNCT03293784: TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma

Sponsor: Institut Claudius Regaud. Phase: PHASE1. Conditions: Melanoma

full page →ctgov ↗

RECRUITINGphase readoutNCT06582784: IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Depression, Depressive Symptoms, Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT06467084: Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

Sponsor: KalVista Pharmaceuticals, Ltd.. Phase: PHASE3. Conditions: Hereditary Angioedema

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07110233: Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05327452: Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study

Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Breast Cancer, Colorectal Cancer, Prostate Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07411352: Left Lateral Position vs Supine Position to Reduce Active Labor Duration

Sponsor: Universidad Nacional Autonoma de Honduras. Phase: NA. Conditions: Labor Pain

full page →ctgov ↗

COMPLETEDphase readoutNCT07225647: A Study to Assess the Effect of Food on the Drug Levels of Admilparant

Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗

COMPLETEDphase readoutNCT06459947: Effect of Cyanoacrylate and Concentrated Growth Factor on Palatal Donor Site

Sponsor: Yuzuncu Yil University. Phase: NA. Conditions: Wound Healing, Pain, Patient Comfort

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07498647: Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia

Sponsor: BioRay Pharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Gout and Hyperuricemia

full page →ctgov ↗

TERMINATEDphase readoutNCT05341349: Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Sponsor: Emory University. Phase: PHASE1. Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma, Metastatic Mucosal Melanoma, Metastatic Ocular Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8

full page →ctgov ↗

RECRUITINGphase readoutNCT07470749: Frequency of MAFLD and Its Association With Nutritional Status and Metabolic Risk Factors in a Rural Population of Bangladesh

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. Phase: . Conditions: MAFLD, Metabolic Abnormalities, Obesity & Overweight

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04837833: An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Pancreas Cancer, Gastrointestinal Adenocarcinoma

full page →ctgov ↗

COMPLETEDphase readoutNCT05306938: Adolescent Wellness Visits in Tanzania

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: HIV Testing, Contraceptive Usage

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07489352: N-of-1 Trial to Promote Beta-Blocker Titration in Heart Failure

Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Heart Failure, Beta-blocker, Older Adults

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07523152: Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: NA. Conditions: Pelvic Cancer, Anal Cancer, Vaginal Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT04279158: Attention Modulation of Local and Global Inhibition Mechanisms

Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Optical Phenomena

full page →ctgov ↗

RECRUITINGphase readoutNCT07118358: BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System

Sponsor: Biotronik, Inc.. Phase: NA. Conditions: Leadless Pacemaker, Bradycardia, AV Block, Cardiac Rhythm Disorder

full page →ctgov ↗